Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome

Comment

Jean-Claude Davin et al. Pediatr Nephrol. 2011 Oct.

. 2011 Oct;26(10):1915-6.

doi: 10.1007/s00467-011-1925-7. Epub 2011 Jun 7.

No abstract available

Comment in

Optimizing treatment strategies in paediatric atypical hemolytic uremic syndrome.
Waters A. Waters A. Pediatr Nephrol. 2011 Oct;26(10):1917-8. doi: 10.1007/s00467-011-1930-x. Epub 2011 Jun 7. Pediatr Nephrol. 2011. PMID: 21647645 No abstract available.

aHUS caused by complement dysregulation: new therapies on the horizon.
Waters AM, Licht C. Waters AM, et al. Pediatr Nephrol. 2011 Jan;26(1):41-57. doi: 10.1007/s00467-010-1556-4. Epub 2010 Jun 18. Pediatr Nephrol. 2011. PMID: 20556434 Free PMC article. Review.

1. Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26:41–57. doi: 10.1007/s00467-010-1556-4. - DOI - PMC - PubMed
1. Olie KH, Goodship TH, Verlaak R, Florquin S, Groothoff JW, Strain L, Weening JJ, Davin JC. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir. Am J Kidney Dis. 2005;45:e12–15. doi: 10.1053/j.ajkd.2004.09.012. - DOI - PubMed
1. Davin JC, Strain L, Goodship TH. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatr Nephrol. 2008;23:1517–1521. doi: 10.1007/s00467-008-0833-y. - DOI - PMC - PubMed
1. Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor M, Van de Kar N, VandeWalle J, Zimmerhackl L. The European Paediatric Study Group for HUS. Pediatr Nephrol. 2009;24:687–696. doi: 10.1007/s00467-008-0964-1. - DOI - PubMed